SCHEDULE: Vanguard Group Discloses 5.82% Passive Stake in Clover Health

Sentiment:

Beneficial Ownership Report


The Vanguard Group has reported a passive beneficial ownership of 5.82% in Clover Health Investments Corp, holding over 24 million shares of common stock.

Summary

  • The Vanguard Group, an investment adviser based in Pennsylvania, has filed a Schedule 13G indicating beneficial ownership in Clover Health Investments Corp.
  • As of June 30, 2025, Vanguard beneficially owns an aggregate of 24,246,034 shares of Clover Health's Common Stock.
  • This ownership represents 5.82% of the total class of securities.
  • Vanguard holds sole dispositive power over 23,337,346 shares and shared dispositive power over 908,688 shares.
  • Vanguard has no sole voting power but holds shared voting power over 489,384 shares.
  • The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The filing indicates a significant, passive institutional stake by a major asset manager, which is generally a neutral to slightly positive signal of long-term interest, but does not provide operational or financial performance details.

Positives

  • The disclosure of a significant 5.82% stake by a major institutional investor like The Vanguard Group can signal institutional confidence and long-term interest in Clover Health Investments Corp.

Future Outlook

NA

Industry Context

This filing reflects a standard passive investment by a large asset manager like The Vanguard Group, whose investment strategies often involve broad market exposure. It indicates continued institutional interest in the healthcare sector, specifically in companies like Clover Health, but does not provide specific insights into broader industry trends or competitive dynamics.

Stakeholder Impact

  • Shareholders: The disclosure of a significant stake by a major institutional investor like Vanguard can provide a degree of stability and confidence, indicating a large, passive holder in the company's stock.

Key Dates

DateDescription
06/30/2025Date of event which required the filing of this statement (reporting period end date).
07/29/2025Date the Schedule 13G was signed by The Vanguard Group.

Keywords

Clover Health Investments Corp, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment, Healthcare, Managed Care

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.